Philips agrees to acquire SpectraWAVE Inc., advancing next-generation coronary intravascular imaging and physiological assessment with AI December 15, 2025 Acquisition of SpectraWAVE’s next-generation technologies including HyperVueTM Imaging System with Enhanced Vascular Imaging for comprehensive, rapid, and AI-supported imaging inside the coronary arteries, and X1TM-FFR, an AI-enabled angio-based FFR technology that delivers rapid, accurate coronary physiology assessment from a single angiogram [1] SpectraWAVE’s technologies have the potential to significantly increase adoption of corona...
Nous avons organisé un roadshow en Amérique du Nord avec Jean-Michel Bonamy, Deputy CFO. Le message reste positif sur la tendance organique pour le T4 et 2026. Nous en ressortons avec une conviction renforcée sur le momentum 2026 et au-delà avec une solide croissance de BPA, et, selon nous, un possible recours accru au rachat d’actions si l'enveloppe de M&A devait ne pas être dépensée en totalité. Nous réitérons notre opinion Surperformance sur le titre avec un objectif de cours porté à 115 € (v...
We organised a road show in North America with Jean-Michel Bonamy, Deputy CFO. The message remains positive about the organic trend for Q4 and 2026. We have come away with a stronger belief in the 2026 momentum and beyond, with solid EPS growth and, in our view, potential increased use of share buybacks if the M&A envelope is not spent in full. We reiterate our Outperform rating on the stock with a target price adjusted to € 115 (vs € 110) as a result of a slight increase in our long-term margin...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.